Consistent with previous studies, ARTS in combination with dFdC inhibited DMBA-induced pancreatic cancer in mice (Figure 6), implying that ARTS could overcome dFdC resistance in pancreatic cancer by suppressing c-Myc and PD-L1 expression. Here, CD274 is linked to familial pancreatic carcinoma.